Abstract:Epidermal-growth-factor receptor[1] (EGFR) is a polypeptide with 1186 amino acids, which binds to EGF family growth factors. Two major natural ligands in the family interact with EGFR: one is EGF, the other is transforming growth factor-α (TGF-α)[2]. When EGF or TGF-α, binds to EGFR, tyrosine kinase activity is induced which in turn triggers a series of events regulating the cell growth[3-8]. The importance of EGFR in growth regulating pathways was confirmed by the fact that enhanced expression of this receptor was found in brain glioblastomas, breast, lung, ovarian, colorectal, and renal carcinomas[9,10]. Elevated EGFR levels correlated with poor prognosis in human tumors[11-17], for this reason, it seemed to be that EGFR would be a logical target for cancer therapy. Previous reports had shown that monoclonal antibodies to EGFR were effective in the treatment of many human carcinoma cells[18-20]. Other drug therapies which targeted the EGFR had also been successful. Kunkel had shown a drug that inhibited EGFR tyrosine kinase activity could inhibit the growth of A431 cells in nude mice[10]. Yoneda also reported that selective inhibitors of EGFR tyrosine kinase activity, such as tyrphostins, could inhibit the growth of squamous carcinoma in nude mice[21]. Antisense oligodeoxynucleotides inhibit gene expression on a highly selective and target sequence in a specific manner[22-25]. Specific oligonucleotides hybridize to complementary mRNA and decrease protein expression[26-29]. Antisense oligonucleotides against proto-oncogenes of growth factors had already been shown to be successful in cell lines[18,30]. For example, an antisense oligonucleotide to the erB2 gene product had been shown to inhibit protein production in a breast cancer cell line[31]. Akino reported inhibition of in vivo growth and metastases in malignant pituitary tumors with an antisense compound to the PTHrp (parathyroid hormone-related peptide)[32]. An oligonucleotide to the c-myc gene inhibited the growth of thyroid carcinoma cell lines[33]. Phosphorothioate antisense oligodeoxynucleotides targeted against human c-raf-1 kinase producing potent antiproliferative effects on cell culture and in vivo antitumor effects against a variety of tumor types[34]. The co-expression of EGFR along with TGF-α in human colon cancer cell lines, also in colon carcinoma tissue, had led to the suggestion that the autocrine stimulation of EGFR by its ligands could be a mechanism for tumor cells to escape from normal growth controls[35]. Previous studies in our laboratory confirmed over-expression of EGFR in HR8348 cells[36]. In this investigation, we hypothesized that growth and proliferation of HR8348 could be inhibited by EGFR ASODN. In this report 15-mer EGFR ASODN was synthesized and the effects of EGFR ASODN on cell proliferation and tumorigenic rate of HR8348 cells were observed.

Effect of Antisense Oligodexynucelotide Specific to KDR Gene on Human Gastric Carcinoma Cell

Effect of KDR gene- specific antisense oligodeoxynucleotide on human vascular endothelial cell

[Effects of Vascular Endothelial Growth Factor (VEGF) Antisense Oligodeoxynucleotide on Mrna and Expression of VEGF, Flt-1, and Kinase Insert Domain Containing Receptor and VEGF Excretion in Human Gallbladder Carcinoma Cells].

The Role of KDR in the Interactions Between Human Gastric Carcinoma Cell and Vascular Endothelial Cell.

The Role of Vascular Endothelial Growth Factor Receptor (KDR) in Invasion and Metastasis of Gastric Cancer

EFFECTS OF DIFFERENT CONCENTRATIONS OF ANTISENSE OLIGODEOXYNUCLEOTIDES(ASODN) ON HUMAN PANCREATIC CANCER CELL LINE PaTu8988s

Effect of antisense oligodeoxynucelotide specific to ki-Ras gene on human gastric carcinoma cells and human vascular endothelial cells

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Effect of K‐ras Antisense Oligodeoxynucleotides on Human Pancreatic Cancer Cell Line PaTu 8988S

Effect of KDR Antisense Oligonucleotides on Growth of Human Breast Cancer Cells

The Effect of Anti-vascular Endothelial Growth Factor and Receptor Antibody on the Proliferation Activity and Apoptosis of Human Gastric Cancer

Study on proliferation inhibition effect of KDR ASODN in human prostate cancer cell line PC-3

Inhibitory Effects of Egfr Antisense Oligodeoxynucleotide in Human Colorectal Cancer Cell Line

[Effect of VEGFR1 Gene Silencing by Shrna on Proliferation, Migration and Apoptosis of U937 Line].

Effects of the Expression of KDR in AGS Cells on the Biological Behavior of HUVECs

The Comparison of Antisense Oligonucleotides、small Interferingrna Targeting KDR for Gene Silencing

Effect of inhibiting mdr1 on radiosensitivity in cervical carcinoma xenografts

Effect of Human Telomerase Antisense Oligodeoxyribonucleotides on the Growth Inhibition of Gastric Cancer Cell Lines with Well, Moderate and Poor Differentiation

Inhibitory Effects of TGF-α Antisense Oligodeoxynucleotide and EGFR Antisense Oligodeoxynucleotide with Liposome on Human Colorectal Cancer Cell Line

Effect of Integrin-Linked Kinase Antisense Oligonucletide on Human Gastric Cancer Cell Line

VEGF165 antisense gene and biological characteristics of human gastric cancer cells